Companies / Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.

Nasdaq: IOVACIK 1425205SAN CARLOS, CAiovance.com ↗

Financials · FY2025

Revenue$263.50M
Net income$-390.98M
Total debt—
Cash$110.77M
Diluted EPS$-1.09
Shares outstanding453.0M

Ownership

453.0M shares outstanding · as of Jul 29, 2026
0.23%Insiders
Ownership
Insiders0.23%1,033,915
10%+ / strategic5.40%24,478,268
Institutions59.41%269,099,019
Public float34.96%158,360,230

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Vogt Frederick GCEOInterim CEO & General Counsel · Director
0.12%529,538
Puri Raj K.Chief Regulatory Officer
0.05%239,230
Kirby Daniel GordonChief Commercial Officer
0.03%139,381
Graf Finckenstein FriedrichFormerChief Medical Officer
0.03%131,957
Bilinsky IgorChief Operating Officer
0.03%125,766
Maynard Ryan DDirector
——
Roche Corleen M.Chief Financial Officer
——
Weiser MichaelDirector
——

Institutional holders 272

View all →
HolderValue% of shares
BlackRock, Inc.$153.74M8.16%
State Street Corporation$101.83M5.40%
Mhr Fund Management LLC$101.67M6.39%
Vanguard Group Inc$74.28M6.01%
Two Sigma Investments, LP$48.04M3.02%
Bank of America Corp /De$38.98M3.15%
Millennium Management LLC$33.04M2.08%
Invenomic Capital Management LP$32.65M2.64%
Geode Capital Management, LLC$30.10M1.89%
D. E. Shaw & Co., Inc.$28.14M1.77%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 24, 2026Kirby Daniel Gordon
Executive
OtherCommon Stock$129.1K-34K
-19.69%
139,381
0.03% of shares
low
Mar 5, 2026Vogt Frederick G
CEO
OtherCommon Stock$122.5K-27K
-4.81%
529,538
0.12% of shares
low
Mar 2, 2026Vogt Frederick G
CEO
OtherCommon Stock$86.4K-23K
-4.42%
493,800
0.11% of shares
low
Mar 5, 2026Puri Raj K.
Executive
OtherCommon Stock$84.1K-18K
-7.13%
239,230
0.05% of shares
low
Mar 5, 2026Bilinsky Igor
Executive
OtherCommon Stock$76.2K-17K
-11.68%
125,766
0.03% of shares
low
Mar 5, 2026Graf Finckenstein Friedrich
Executive
OtherCommon Stock$75.7K-17K
-11.13%
131,957
0.03% of shares
low
Feb 10, 2026Kirby Daniel Gordon
Executive
OtherCommon Stock$42.8K-16K
-23.50%
53,546
0.01% of shares
low
Mar 2, 2026Graf Finckenstein Friedrich
Executive
OtherCommon Stock$27.0K-7K
-5.73%
117,231
0.03% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G—24,478,268—
Vanguard Group IncPassive13G/A—0—
State Street CorporationPassive13G—20,161,445—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IOVA——462260100—